Annual Shareholders Equity
$437.28 M
+$3.48 M+0.80%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual stockholders equity is $437.28 million, with the most recent change of +$3.48 million (+0.80%) on December 31, 2023.
- During the last 3 years, ZNTL annual shareholders equity has risen by +$128.70 million (+41.71%).
- ZNTL annual shareholders equity is now at all-time high.
Performance
ZNTL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$354.33 M
-$28.25 M-7.38%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly stockholders equity is $354.33 million, with the most recent change of -$28.25 million (-7.38%) on September 30, 2024.
- Over the past year, ZNTL quarterly shareholders equity has dropped by -$127.44 million (-26.45%).
- ZNTL quarterly shareholders equity is now -32.27% below its all-time high of $523.14 million, reached on June 30, 2023.
Performance
ZNTL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ZNTL Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.8% | -26.4% |
3 y3 years | +41.7% | -26.4% |
5 y5 years | +1665.4% | -26.4% |
ZNTL Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +20.1% | -32.3% | +12.4% |
5 y | 5-year | at high | +645.9% | -32.3% | +469.5% |
alltime | all time | at high | +645.9% | -32.3% | +469.5% |
Zentalis Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $354.33 M(-7.4%) |
Jun 2024 | - | $382.58 M(-16.6%) |
Mar 2024 | - | $458.77 M(+4.9%) |
Dec 2023 | $437.28 M(+0.8%) | $437.28 M(-9.2%) |
Sep 2023 | - | $481.77 M(-7.9%) |
Jun 2023 | - | $523.14 M(+35.7%) |
Mar 2023 | - | $385.49 M(-11.1%) |
Dec 2022 | $433.80 M | $433.80 M(+1.2%) |
Sep 2022 | - | $428.50 M(-9.3%) |
Jun 2022 | - | $472.49 M(+49.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $315.30 M(-13.4%) |
Dec 2021 | $363.95 M(+17.9%) | $363.95 M(-7.5%) |
Sep 2021 | - | $393.43 M(+75.8%) |
Jun 2021 | - | $223.84 M(-16.6%) |
Mar 2021 | - | $268.39 M(-13.0%) |
Dec 2020 | $308.58 M(-485.2%) | $308.58 M(-9.5%) |
Sep 2020 | - | $341.06 M(+60.0%) |
Jun 2020 | - | $213.22 M(-322.3%) |
Mar 2020 | - | -$95.90 M(+19.7%) |
Dec 2019 | -$80.11 M(-423.4%) | -$80.11 M |
Dec 2018 | $24.77 M | - |
FAQ
- What is Zentalis Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual shareholders equity year-on-year change?
- What is Zentalis Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Zentalis Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ZNTL is $437.28 M
What is the all time high annual shareholders equity for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual stockholders equity is $437.28 M
What is Zentalis Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ZNTL annual stockholders equity has changed by +$3.48 M (+0.80%)
What is Zentalis Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ZNTL is $354.33 M
What is the all time high quarterly shareholders equity for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly stockholders equity is $523.14 M
What is Zentalis Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ZNTL quarterly stockholders equity has changed by -$127.44 M (-26.45%)